217 related articles for article (PubMed ID: 21555290)
21. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007.
Winston S; Lin YS
J Am Pharm Assoc (2003); 2009; 49(6):813-20. PubMed ID: 19858047
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of a Medicare Part D telephone medication therapy management program.
Moczygemba LR; Barner JC; Gabrillo ER
J Am Pharm Assoc (2003); 2012; 52(6):e144-52. PubMed ID: 23229976
[TBL] [Abstract][Full Text] [Related]
23. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
;
J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
[TBL] [Abstract][Full Text] [Related]
24. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
[TBL] [Abstract][Full Text] [Related]
25. TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate.
Luder HR; Frede SM; Kirby JA; Epplen K; Cavanaugh T; Martin-Boone JE; Conrad WF; Kuhlmann D; Heaton PC
J Am Pharm Assoc (2003); 2015; 55(3):246-54. PubMed ID: 26003155
[TBL] [Abstract][Full Text] [Related]
26. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up.
Moczygemba LR; Barner JC; Lawson KA; Brown CM; Gabrillo ER; Godley P; Johnsrud M
Am J Geriatr Pharmacother; 2011 Oct; 9(5):328-38. PubMed ID: 21865093
[TBL] [Abstract][Full Text] [Related]
27. Patients' value of asthma services in Australian pharmacies: the way ahead for asthma care.
Naik-Panvelkar P; Armour C; Rose J; Saini B
J Asthma; 2012 Apr; 49(3):310-6. PubMed ID: 22348432
[TBL] [Abstract][Full Text] [Related]
28. Analyzing the costs to deliver medication therapy management services.
Rupp MT
J Am Pharm Assoc (2003); 2011; 51(3):e19-26; quiz e27. PubMed ID: 21555277
[TBL] [Abstract][Full Text] [Related]
29. Retrospective financial analysis of medication therapy management services from the pharmacy's perspective.
McDonough RP; Harthan AA; McLeese KE; Doucette WR
J Am Pharm Assoc (2003); 2010; 50(1):62-6. PubMed ID: 20097640
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
Christensen DB; Roth M; Trygstad T; Byrd J
J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
[TBL] [Abstract][Full Text] [Related]
31. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
Almodóvar AS; Nahata MC
J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
[TBL] [Abstract][Full Text] [Related]
32. Clinical and economic outcomes of medication therapy management services: the Minnesota experience.
Isetts BJ; Schondelmeyer SW; Artz MB; Lenarz LA; Heaton AH; Wadd WB; Brown LM; Cipolle RJ
J Am Pharm Assoc (2003); 2008; 48(2):203-214. PubMed ID: 18359733
[TBL] [Abstract][Full Text] [Related]
33. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries.
Moczygemba LR; Barner JC; Gabrillo ER; Godley PJ
Am J Health Syst Pharm; 2008 Sep; 65(17):1655-60. PubMed ID: 18714113
[TBL] [Abstract][Full Text] [Related]
34. College of pharmacy-based medication therapy management program for a university system.
Stratton TP; Cernohous T; Hager K; Bumgardner M; Traynor A; Worley MM; Isetts BJ; Larson T; Seifert R
J Am Pharm Assoc (2003); 2012; 52(5):653-60. PubMed ID: 23023847
[TBL] [Abstract][Full Text] [Related]
35. Dispelling the myths about medication therapy management services.
Martin CM; McSpadden CS
Consult Pharm; 2008 Nov; 23(11):866-72, 875. PubMed ID: 19072011
[TBL] [Abstract][Full Text] [Related]
36. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians.
Lauffenburger JC; Vu MB; Burkhart JI; Weinberger M; Roth MT
Am J Geriatr Pharmacother; 2012 Apr; 10(2):129-38. PubMed ID: 22284582
[TBL] [Abstract][Full Text] [Related]
37. Medication therapy management services: definitions and outcomes.
Pellegrino AN; Martin MT; Tilton JJ; Touchette DR
Drugs; 2009; 69(4):393-406. PubMed ID: 19323584
[TBL] [Abstract][Full Text] [Related]
38. Self-reported responses to medication therapy management services for older adults: analysis of a 5-year program.
Cook DM; Moulton PV; Sacks TM; Yang W
Res Social Adm Pharm; 2012; 8(3):217-27. PubMed ID: 21955807
[TBL] [Abstract][Full Text] [Related]
39. Patients' willingness to pay for cognitive pharmacist services in community pharmacies.
Lakić D; Stević I; Odalović M; Vezmar-Kovačević S; Tadić I
Croat Med J; 2017 Oct; 58(5):364-371. PubMed ID: 29094815
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries.
Tsang CCS; Shih YT; Dong X; Garuccio J; Browning JA; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Zeng R; Wang J
Value Health; 2023 May; 26(5):649-657. PubMed ID: 36376143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
